AFAli Faramarzi

Ali Faramarzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Faramarzi has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Application of Bone Allograft in Mastoid Obliteration After Mastoidectomy

    by Mohammad Faramarzi, Amirhossein Babaei, Ali Faramarzi, Hamed Sajjadi

    BACKGROUND: Mastoid obliteration after canal wall down mastoidectomy (CWDM) is recommended to reduce both complications and recurrence. In this study, the bone allograft was used for mastoid obliteration in large cavities and reconstruction of the external auditory canal (EAC) after retrograde CWDM. METHODS: This is a prospective, single-arm, open-label trial. Inclusion criteria were adult patients (>18 years old) who had undergone retro grade CWDM due to chronic otitis media with cholesteatoma. Bone allograft was used for mastoid obliteration in large cavities and for EAC reconstruction. RESULTS: Ninety patients completed the study. Granulation tissue developed in 27 (30%) patients; it was mild and was managed by applying 5% trichloroacetic acid in 24 patients. Three patients underwent revision surgery due to severe granulation tissue formation. Otorrhea was observed in all 27 patients with granulation tissue (30%), but it was stopped after the application of trichloroacetic acid in 24 patients. Persistent otorrhea was reported only in 3 patients with severe granulation tissue formation. In 87 patients (96.67%), epithelialization of the mastoid cavity was completed after 2 months of follow-up. No cavity problems or bone pâté infections were seen. CONCLUSION: Due to their availability and affordability, bone allografts present a practical option for obliteration of large mastoid cavities and reconstruction of the EAC in retrograde CWDM procedures.

  • Open Access

    Top Performers in a Decade of Otolaryngology Research: A Bibliometric Analysis (2015–2024)

    by Ali Faramarzi

    Objective To analyze worldwide otorhinolaryngology publications from 2015–2024 and identify the top-performing countries, journals, funding agencies, organizations, and individual researchers. Methods A cross-sectional bibliometric analysis of the Web of Science Core Collection was conducted using Clarivate’s InCites, restricting results to the “Otorhinolaryngology” research area from 2015–2024 (data updated March 28, 2025). Primary metrics included publication counts, total citations, and category-normalized citation impact (CNCI). Secondary measures included the percentage of publications in the top 1% and 10% by citations, in first-quartile (Q1) journals, and with international co-authorship. Results A total of 95,435 otolaryngology publications were identified. The United States led in output (31,654 publications) and citations (342,724), with 1.57% in the top 1% by citations. Germany (7,036 publications) and China (6,447) were next largest. Italy achieved the highest citation impact among major countries (CNCI 1.77). The Laryngoscope was the most prolific journal (6,757 articles), whereas JAMA Otolaryngology–Head & Neck Surgery had the highest citation impact (CNCI 1.91). The US National Institutes of Health and the National Natural Science Foundation of China were the top funders, supporting 5,063 and 1,761 publications, respectively. Harvard University (including affiliates) produced over 7,000 publications, and Jerome R. Lechien was the most prolific author (387 publications, CNCI 3.64). International collaborations accounted for 13.5% of all publications. Conclusion Global otolaryngology research over the past decade has been dominated by a few countries and institutions, particularly in the United States. These findings highlight disparities in research output and can inform strategies to broaden international collaboration and strengthen emerging research centers.

  • Open Access

    Refining Pure-Tone Average Calculations for Reporting Hearing Outcomes: Advocating a Shift to the Logarithmic Mean

    by Ali Faramarzi

    Dear Editor, Uniformity in reporting hearing outcomes is paramount for accurate evaluation and comparison of hearing-related research. Standardized guidelines are essential as, without them, comparing data between studies becomes problematic. One widely accepted method is the 4-frequency pure-tone average (PTA), using frequencies of 0.5, 1, 2, and 3 kHz. This approach was first recommended in the 1979 American Medical Association (AMA) guidelines for calculating hearing handicap.[1] Subsequently, the AMA's chosen frequencies were incorporated into the 1995[2] [3] and 2012[4] guidelines issued by the Hearing and Equilibrium Committee of the American Academy of Otolaryngology—Head and Neck Surgery (AAO-HNS). These guidelines for reporting hearing results are still recommended and used today.[2] [3] [4] Traditionally, the calculation of PTA has followed the guidelines set forth by renowned institutions such as the AMA[1] and the AAO-HNS.[2] [3] [4] These bodies initially proposed the simple arithmetic mean (SAM) as the method for calculating PTA.[1] However, considering the decibel (dB) scale's inherent logarithmic structure,[5] this may not accurately represent PTA values. This understanding necessitates a critical reevaluation of current practices, suggesting that a logarithmic mean might yield more accurate results than the SAM. For instance, on a logarithmic scale, the average of 10 and 30 dB is not 20 dB but approximately 27.03 dB. This proposed analytical shift, aligning with the dB scale's inherent logarithmic nature, could potentially facilitate a more precise determination of PTA. The steps to achieve this are as follows: The reevaluation of hearing outcome reporting guidelines[1] [2] [3] [4] shows that the recommended PTA calculation formula is the SAM, which might be inappropriate for a logarithmic measure such as the dB scale. This underlines the importance of accurate and appropriate reporting of PTAs, since such data plays a pivotal role in diagnosis and treatment decisions. For greater accuracy, a shift from the SAM to the logarithmic mean should be considered. While it is acknowledged that implementing new standards often requires a transition period, it is essential to recognize that the proposed formula utilizes routinely collected data, merely suggesting a different approach to calculating averages. Consequently, the transition period is expected to be relatively brief. Hence, a thoughtful revision of the guidelines on reporting hearing outcomes is needed. This modification, which is essential for the sake of accuracy, can be implemented effectively. Thus, we can bring about improvements in the quality and consistency of data reporting in hearing healthcare, thereby enabling a more precise and meaningful comparison between studies. The data that support the findings of this study are available from the authors upon reasonable request. Ali Faramarzi – https://orcid.org/0000-0003-4814-1729 Received: 07 October 2024 Accepted: 18 November 2024 Article published online: 11 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

  • Comparative Mortality and Risk Analysis in Mucormycosis Cases: Pre-Pandemic Versus COVID-19 Association

    by Masoud Janipour, Alireza Shahriari, Ali Faramarzi, Seyed Hossein Owji, Mohammad Ehsan Golshannia, Maryam Kherad, Maryam Rahimi, Vahid Hajianpour, Behzad Khademi, Amirhossein Babaei

    Objectives This study aims to compare the clinical profiles, outcomes, and mortality-related risk factors of COVID-19-associated mucormycosis (CAM) with cases identified before the pandemic. Additionally, it seeks to evaluate the impact of the COVID-19 pandemic on the epidemiology and severity of mucormycosis infections. Study Design Retrospective, observational study. Setting The study was conducted across multiple medical centers in Shiraz, Iran. Methods We reviewed clinical data of patients diagnosed with mucormycosis before and during the COVID-19 pandemic. The study included a detailed analysis of demographic profiles, clinical characteristics, risk factors, treatment outcomes, and mortality. Mortality-related risk factors were specifically analyzed through logistic regression models to identify predictors of poor outcomes in CAM patients. Results The study included 122 cases of mucormycosis, with 85 cases associated with COVID-19. Patients with CAM showed higher prevalences of diabetes mellitus and hypertension compared to pre-pandemic cases, while malignancies were higher in peri-pandemic cases than in CAM cases (p < 0.05). CAM cases also demonstrated significantly higher in-hospital mortality (23.1%) compared to pre-pandemic cases (7.7%). Elevated platelet counts and the presence of periorbital edema were more commonly observed in CAM patients. Mortality-based analysis indicated that malignancies and high platelet counts were significant predictors of mortality in CAM patients. Conclusion COVID-19 has markedly affected the severity and mortality of mucormycosis, with CAM cases showing worse outcomes than pre-pandemic incidences. Our study emphasizes the need for aggressive management and increased awareness of risk factors to enhance survival rates in CAM patients during the pandemic.

  • The effect of 5% and 10% povidone-iodine antiseptic concentrations on postoperative sensorineural hearing loss in tympanoplasty: a triple-blind randomized clinical trial

    by Mohammad Faramarzi, Ali Faramarzi, Sareh Roosta, Mahmoud Shishegar, Mohammadreza Khademalizadeh, Sara S. Nabavizadeh, Amir Keyvan Sazgar

    Purpose To evaluate the ototoxicity of povidone iodine (PVP-I) at concentrations of 5% and 10% during tympanoplasty by assessing frequency-specific audiometric outcomes and graft success rates in a large cohort of patients. Methods This prospective, triple-blinded, randomized clinical trial enrolled 542 patients undergoing primary tympanoplasty. After excluding patients for inadequate follow-up, 204 ears received 10% PVP-I and 199 ears received 5% PVP-I. Audiometric evaluations, including bone conduction (BC), air conduction (AC), air-bone gap (ABG), and speech reception threshold (SRT), were conducted preoperatively and 12 months postoperatively. The primary outcome was the incidence of sensorineural hearing loss (SNHL), defined as an increase in BC threshold of more than 10 dB. Secondary outcomes included graft success rate and audiometric gains. Results The overall incidence of SNHL was 1.5% in the 10% PVP-I group and 1.0% in the 5% PVP-I group, with no significant difference (P = 1.000). In ears with preoperative mixed hearing loss, SNHL at 0.25 kHz was significantly higher in the 10% PVP-I group (28.9%) compared to the 5% PVP-I group (6.7%) (P = 0.002). Graft success rates were 94.1% and 97.0% in the 10% and 5% PVP-I groups, respectively (P = 0.164). No clinically significant differences in audiometric gains were observed between the groups. Conclusion Both 5% and 10% PVP-I concentrations are safe for antiseptic preparation in tympanoplasty, as evidenced by low rates of SNHL and high graft success rates. These findings support the use of PVP-I in human otologic surgery without significant ototoxic risk.

  • Open Access

    The relationship between cleft palate repair technique and audiological outcomes: A retrospective cohort study

    by Tayebeh Kazemi, Sara S. Nabavizadeh, Nasser Nadjmi, Alireza Ahmadkhani, Parvin Ghaemmaghami, Ardavan Kafaei, Ali Faramarzi

    Objective: Otitis media with effusion is common in children with cleft palates. This study aimed to investigate the link between palatal closure techniques and audiological outcomes.Methods: In this retrospective‐prospective cohort study, we examined the relationship between palate repair techniques and hearing outcomes in children with cleft palates. From 2017 to 2022, 190 ears of 95 cleft patients were studied at the Cleft Lip and Palate Department of Shiraz University of Medical Sciences. Variables assessed included the surgical technique, cleft severity, auditory brainstem response (ABR) threshold, and tympanometry configuration.Results: The mean ABR improved from a prepalatoplasty value of 39.51(11.62) decibels (dB) to a postpalatoplasty mean of 26.61(11.60) dB (Cohen's d: 1.12 [95% CI; 0.90–1.34]). Initially, 87.9% of the studied ears exhibited abnormal tympanometry, but this significantly decreased to 47% postsurgery (risk ratio: 4.43 [95% CI; 1.20–16.43]). When compared with Sommerlad intravelar veloplasty, the Nadjmi modified Furlow palatoplasty was associated with a notably lower mean ABR (β: −6.58 [95% CI: −10.43 to −2.73], p‐value = .001) and a reduced frequency of abnormal tympanometry (odds ratio [OR]: −1.10; 95% CI: −1.85 to −0.36, p‐value = .004). Factors like prepalatoplasty ABR, cleft palate severity, gender, and syndromic did not confound these findings.Conclusions: Although the Nadjmi modified Furlow palatoplasty showed better results, our findings indicate a significant improvement in ABR and tympanometry outcomes for both techniques. Future randomized controlled trials are suggested to confirm the influence of palatal closure techniques on audiological outcomes.Level of Evidence: 3b.